{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:10:38Z","timestamp":1784257838088,"version":"3.55.0"},"reference-count":102,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), a unique beta-coronavirus, has caused the most serious outbreak of the last century at the global level. SARS-CoV-2 infections were firstly reported in the city of Wuhan in China in 2019 and this new disease was named COVID-19 by World Health Organization (WHO). As this novel disease can easily be transmitted from one individual to another <jats:italic>via<\/jats:italic> respiratory droplets, many nations around the world have taken several precautions regarding the reduction in social activities and quarantine for the limitation of the COVID-19 transmission. SARS-CoV-2 is known to cause complications that may include pneumonia, acute respiratory distress syndrome (ARDS), multi-organ failure, septic shock, and death. To prevent and treat COVID-19, some significant studies have been conducted since the outbreak. One of the most noticeable therapeutic approaches is related to a multifunctional protein, lactoferrin. Lactoferrin (Lf) is an 80 kDa cationic glycoprotein that has a great range of benefits from improving the immunity to antiviral effects due to its unique characteristics such as the iron-binding ability. This review summarizes the characteristics of SARS-CoV-2 and the potential applications of Lf for the prevention, treatment, and recovery of COVID-19.<\/jats:p>","DOI":"10.3389\/fnut.2022.992733","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T06:31:31Z","timestamp":1667802691000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Lactoferrin for COVID-19 prevention, treatment, and recovery"],"prefix":"10.3389","volume":"9","author":[{"given":"Ecem","family":"Bolat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furkan","family":"Eker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"Duman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fenur","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcmeyye","family":"Sarita\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif Sercan","family":"\u015eahuto\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sercan","family":"Karav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1758788","article-title":"Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment","volume":"39","author":"Boopathi","year":"2020","journal-title":"J Biomol Struct Dyn."},{"key":"B2","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: current state of the science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity."},{"key":"B3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.34293\/sijash.v8is1-feb.3931","article-title":"A review on COVID19: evolution, structure of corona virus and comparison of COVID19 with common FLU","volume":"8","author":"Mahendra","year":"2021","journal-title":"Shanlax Int J Arts Sci Humanit"},{"key":"B4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1139\/o2012-018","article-title":"Lactoferrin-50 years on","volume":"90","author":"Brock","year":"2012","journal-title":"Biochem Cell Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J Adv Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/B978-0-323-90769-9.00011-6","article-title":"A review on epidemiology, genomic characteristics, spread, and treatments of COVID-19","volume":"2","author":"Bharati","year":"2021","journal-title":"Data Sci COVID-19 Soc Med Perspect."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1099\/0022-1317-69-12-2939","article-title":"Coronaviruses: structure and genome expression","volume":"69","author":"Spaan","year":"1988","journal-title":"J Gen Virol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.30699\/fhi.v9i1.232","article-title":"Corona virus (COVID-19) risk groups: scrutinizing the death cases reported in South Korea","volume":"9","author":"Jeon","year":"2020","journal-title":"Front Heal Informatics."},{"key":"B9","doi-asserted-by":"publisher","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","volume":"109","author":"Rothan","year":"2020","journal-title":"J Autoimmun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1109\/JBHI.2020.3034296","article-title":"Deep learning prognosis model help alert for COVID-19 patients at high-risk of death: a multi-center study","volume":"24","author":"Meng","year":"2020","journal-title":"IEEE J Biomed Heal Informatics."},{"key":"B11","year":"2020","journal-title":"Coronavirus Disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update."},{"key":"B12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.20473\/jkl.v12i1si.2020.121-128","article-title":"Covid19 Pandemic: Management and Global Response","volume":"12","author":"Amir","year":"2020","journal-title":"J Kesehat Lingkung."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1038\/s41467-022-29880-7","article-title":"Trends and associated factors for COVID-19 hospitalisation and fatality risk in 23 million adults in England","volume":"13","author":"Beaney","year":"2022","journal-title":"Nat Commun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"20122753","DOI":"10.1098\/rspb.2012.2753","article-title":"A comparison of bats and rodents as reservoirs of zoonotic viruses: are bats special?","volume":"280","author":"Luis","year":"2013","journal-title":"Proc R Soc B Biol Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"107571","DOI":"10.1016\/j.intimp.2021.107571","article-title":"The potential for lactoferrin to reduce SARS-CoV-2 induced cytokine storm","volume":"95","author":"Zimecki","year":"2021","journal-title":"Int Immunopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"20200173","DOI":"10.1515\/dmdi-2020-0173","article-title":"Drugs intervention study in COVID-19 management","volume":"2021","author":"Taher","year":"2021","journal-title":"Drug Metab Pers Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ijmmb.2022.02.005","article-title":"Basic virology of SARS-CoV 2","volume":"40","author":"Ravi","year":"2022","journal-title":"Indian J Med Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu Rev Virol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbrc.2020.03.047","article-title":"Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection","volume":"526","author":"Luan","year":"2020","journal-title":"Biochem Biophys Res Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"H1084","DOI":"10.1152\/AJPHEART.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"South","year":"2020","journal-title":"Am J Physiol Hear Circ Physiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00415-020-10067-3","article-title":"systematic review of neurological symptoms and complications of COVID-19","volume":"268","author":"Chen","year":"2021","journal-title":"J Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"101701","DOI":"10.1063\/5.0064104","article-title":"Effect of co-flow on fluid dynamics of a cough jet with implications in spread of COVID-19","volume":"33","author":"Behera","year":"2021","journal-title":"Phys Fluids."},{"key":"B23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.redar.2020.08.004","article-title":"Critically ill COVID-19 patients attended by anesthesiologists in northwestern Spain: a multicenter prospective observational study","volume":"68","author":"Taboada","year":"2021","journal-title":"Rev Esp Anestesiol Reanim."},{"key":"B24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12098-020-03263-6","article-title":"Review of coronavirus disease-2019 (COVID-19)","volume":"87","author":"Singhal","year":"2020","journal-title":"Indian J Pediatr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.1016\/j.jmb.2020.07.009","article-title":"Mutations strengthened SARS-CoV-2 infectivity","volume":"432","author":"Chen","year":"2020","journal-title":"J Mol Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"5204","DOI":"10.1016\/j.ygeno.2020.09.028","article-title":"Mutations on COVID-19 diagnostic targets","volume":"112","author":"Wang","year":"2020","journal-title":"Genomics."},{"key":"B27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11908-021-00752-3","article-title":"Status report on COVID-19 vaccines development","volume":"23","author":"Kumar","year":"2021","journal-title":"Curr Infect Dis Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41392-021-00621-4","article-title":"COVID-19 vaccines: progress and understanding on quality control and evaluation","volume":"6","author":"Mao","year":"2021","journal-title":"Signal Transduct Target Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.healthpol.2021.03.013","article-title":"COVID-19 vaccine challenges: what have we learned so far and what remains to be done?","volume":"125","author":"Forman","year":"2021","journal-title":"Health Policy (New York)."},{"key":"B30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.14740\/jocmr4518","article-title":"Review of COVID-19 variants and COVID-19 vaccine efficacy: what the clinician should know?","volume":"13","author":"Vasireddy","year":"2021","journal-title":"J Clin Med Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3126\/jbs.v8i1.38453","article-title":"Global variants of COVID-19: current understanding","volume":"8","author":"Roy","year":"2021","journal-title":"J Biomed Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/clinpract11040093","article-title":"Analysis of the Delta Variant B16172 COVID-19","volume":"11","author":"Shiehzadegan","year":"2021","journal-title":"Clin Pract."},{"key":"B33","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/mco2.95","article-title":"The challenges of COVID-19 Delta variant: prevention and vaccine development","volume":"2","author":"He","year":"2021","journal-title":"MedComm."},{"key":"B34","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/22221751.2022.2037398","article-title":"Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study","volume":"11","author":"Sritipsukho","year":"2022","journal-title":"Emerg Microbes Infect."},{"key":"B35","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4269\/ajtmh.21-0812","article-title":"The dominance of severe acute respiratory syndrome coronavirus 2 B.1.617 and its sublineages and associations with mortality during the COVID-19 pandemic in India between 2020 and 2021.","volume":"106","author":"Venkatraja","year":"2022","journal-title":"Am J Trop."},{"key":"B36","doi-asserted-by":"publisher","first-page":"101606","DOI":"10.1016\/j.bjid.2021.101606","article-title":"The impact of spike mutated variants of SARS-CoV2 (Alpha, Beta, Gamma, Delta, and Lambda) on the efficacy of subunit recombinant vaccines","volume":"25","author":"Mohammadi","year":"2021","journal-title":"Brazilian J Infect Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/ijms18040870","article-title":"Studying lactoferrin N-glycosylation","volume":"18","author":"Karav","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B38","author":"Strate","year":"2001","journal-title":"Anti-Cytomegalovirus Applications of the Intrinsically Active Drug Carrier Lactoferrin."},{"key":"B39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.14715\/cmb\/2018.64.9.8","article-title":"Selective deglycosylation of lactoferrin to understand glycans' contribution to antimicrobial activity of lactoferrin","volume":"64","author":"Karav","year":"2018","journal-title":"Cell Mol Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"646275","DOI":"10.3389\/fnut.2021.646275","article-title":"Potential applications of endo-\u03b2-N-acetylglucosaminidases from bifidobacterium longum subspecies infantis in designing value-added, next-generation infant formulas","volume":"8","author":"Duman","year":"2021","journal-title":"Front Nutr."},{"key":"B41","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.3390\/ijms21144903","article-title":"Lactoferrin as protective natural barrier of respiratory and intestinal mucosa against coronavirus infection and inflammation","volume":"21","author":"Campione","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3389\/fimmu.2020.01221","article-title":"The biology of lactoferrin, an iron-binding protein that can help defend against viruses and bacteria","volume":"11","author":"Kell","year":"2020","journal-title":"Front Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"607443","DOI":"10.3389\/fmolb.2021.607443","article-title":"Molecular mechanisms behind anti SARS-CoV-2 action of lactoferrin","volume":"8","author":"Miotto","year":"2021","journal-title":"Front Mol Biosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6992","DOI":"10.3390\/molecules16086992","article-title":"Antiviral properties of lactoferrin\u2014a natural immunity molecule","volume":"16","author":"Berlutti","year":"2011","journal-title":"Molecules."},{"key":"B45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.antiviral.2014.08.012","article-title":"The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune lactoferrin protein","volume":"111","author":"Picard-Jean","year":"2014","journal-title":"Antiviral Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.bbrc.2013.04.013","article-title":"The protective effects of lactoferrin against murine norovirus infection through inhibition of both viral attachment and replication","volume":"434","author":"Ishikawa","year":"2013","journal-title":"Biochem Biophys Res Commun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/v11010051","article-title":"Bovine lactoferrin prevents influenza a virus infection by interfering with the fusogenic function of viral hemagglutinin","volume":"11","author":"Superti","year":"2019","journal-title":"Viruses."},{"key":"B48","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.nutres.2012.06.006","article-title":"Bovine lactoferrin digested with human gastrointestinal enzymes inhibits replication of human echovirus 5 in cell culture","volume":"32","author":"Furlund","year":"2012","journal-title":"Nutr Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.antiviral.2005.10.006","article-title":"Bovine lactoferrin peptidic fragments involved in inhibition of Echovirus 6 in vitro infection","volume":"69","author":"Pietrantoni","year":"2006","journal-title":"Antiviral Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.1128\/IAI.71.9.5149-5155.2003","article-title":"Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli","volume":"71","author":"Ochoa","year":"2003","journal-title":"Infect Immun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/infdis\/172.2.380","article-title":"Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro","volume":"172","year":"1995","journal-title":"J Infect Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1023\/B:BIOM.0000027691.86757.e2","article-title":"The antimicrobial activity of lactoferrin: current status and perspectives","volume":"17","author":"Orsi","year":"2004","journal-title":"BioMetals."},{"key":"B53","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.siny.2013.02.001","article-title":"Lactoferrin: Antimicrobial activity and therapeutic potential","volume":"18","author":"Embleton","year":"2013","journal-title":"Semin Fetal Neonatal Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0161-5890(03)00152-4","article-title":"Lactoferrin\u2014a multifunctional protein with antimicrobial properties","volume":"40","author":"Farnaud","year":"2003","journal-title":"Mol Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.biochi.2008.05.015","article-title":"Antimicrobial properties of lactoferrin","volume":"91","author":"Jenssen","year":"2009","journal-title":"Biochimie."},{"key":"B56","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-1-4615-2548-6_21","article-title":"Physicochemical and antibacterial properties of lactoferrin and its hydrolysate produced by heat treatment at acidic pH","volume":"357","author":"Saito","year":"1994","journal-title":"Adv Exp Med Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1128\/iai.56.11.2774-2781.1988","article-title":"Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin","volume":"56","author":"Ellison","year":"1988","journal-title":"Infect Immun."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fmicb.2017.00002","article-title":"The antifungal activity of lactoferrin and its derived peptides: mechanisms of action and synergy with drugs against fungal pathogens","volume":"8","author":"Fernandes","year":"2017","journal-title":"Front Microbiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.2174\/138161209788453202","article-title":"Lactoferrin as a natural immune modulator","volume":"15","author":"Actor","year":"2009","journal-title":"Curr Pharm Des."},{"key":"B60","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.nutres.2008.05.007","article-title":"Bovine lactoferrin supplementation supports immune and antioxidant status in healthy human males","volume":"28","author":"Mulder","year":"2008","journal-title":"Nutr Res."},{"key":"B61","first-page":"811","article-title":"Effects of lactoferrin on the immune response modified by the immobilization stress","volume":"57","author":"Zimecki","year":"2005","journal-title":"Pharmacol Rep."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3390\/molecules24071323","article-title":"Lactoferrin in aseptic and septic inflammation","volume":"24","author":"Lepanto","year":"2019","journal-title":"Molecules."},{"key":"B63","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/cei.13108","article-title":"Human lactoferrin attenuates the proinflammatory response of neonatal monocyte-derived macrophages","volume":"192","author":"Wisgrill","year":"2018","journal-title":"Clin Exp Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.foodchem.2012.12.049","article-title":"Antihypertensive effects of lactoferrin hydrolyzates: Inhibition of angiotensin- and endothelin-converting enzymes","volume":"139","author":"Fern\u00e1ndez-Musoles","year":"2013","journal-title":"Food Chem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.3390\/ijms20092128","article-title":"Aerosolized bovine lactoferrin counteracts infection, inflammation and iron dysbalance in a cystic fibrosis mouse model of Pseudomonas aeruginosa chronic lung infection","volume":"20","author":"Cutone","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e0171477","DOI":"10.1371\/journal.pone.0171477","article-title":"Characterization of recombinant human lactoferrin N-glycans expressed in the milk of transgenic cows","volume":"12","author":"Parc","year":"2017","journal-title":"PLoS ONE."},{"key":"B67","doi-asserted-by":"publisher","first-page":"457","DOI":"10.17221\/1978-VETMED","article-title":"Lactoferrin: a review","volume":"53","author":"Adlerova","year":"2008","journal-title":"Vet Med (Praha)."},{"key":"B68","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/adc.67.5.657","article-title":"Biological role of lactoferrin","volume":"67","author":"Sanchez","year":"1992","journal-title":"Arch Dis Child."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jpc.12104","article-title":"Bioactive proteins in breast milk","volume":"49","author":"L\u00f6nnerdal","year":"2013","journal-title":"J Paediatr Child Health."},{"key":"B70","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.virol.2005.01.010","article-title":"Antiviral activity of human lactoferrin: inhibition of alphavirus interaction with heparan sulfate","volume":"333","author":"Waarts","year":"2005","journal-title":"Virology."},{"key":"B71","doi-asserted-by":"publisher","first-page":"14","DOI":"10.19044\/esj.2021.v17n14p14","article-title":"Potential role of lactoferrin and heparin in COVID-19: A review","volume":"17","author":"Hoxha","year":"2021","journal-title":"Eur Sci J ESJ."},{"key":"B72","doi-asserted-by":"publisher","first-page":"8600","DOI":"10.1074\/jbc.RA118.003145","article-title":"Lactoferrin is a natural inhibitor of plasminogen activation","volume":"293","author":"Zwirzitz","year":"2018","journal-title":"J Biol Chem."},{"key":"B73","doi-asserted-by":"publisher","first-page":"10985","DOI":"10.3390\/ijerph182010985","article-title":"Lactoferrin as antiviral treatment in COVID-19 management: preliminary evidence","volume":"18","author":"Campione","year":"2021","journal-title":"Int J Environ Res Public Health."},{"key":"B74","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ijid.2020.05.110","article-title":"Iron: innocent bystander or vicious culprit in COVID-19 pathogenesis?","volume":"97","author":"Edeas","year":"2020","journal-title":"Int J Infect Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"66600","DOI":"10.3389\/fphar.2021.666600","article-title":"Lactoferrin against SARS-CoV-2: in vitro and in silico evidences","volume":"12","author":"Campione","year":"2021","journal-title":"Front Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1128\/AEM.00547-16","article-title":"Oligosaccharides released from milk glycoproteins are selective growth substrates for infant-associated bifidobacteria","volume":"82","author":"Karav","year":"2016","journal-title":"Appl Environ Microbiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"651721","DOI":"10.3389\/fnut.2021.651721","article-title":"Bovine Colostrum and Its Potential for Human Health and Nutrition","volume":"8","author":"Arslan","year":"2021","journal-title":"Front Nutr."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e1000956","DOI":"10.21203\/rs.3.rs-100956\/v2","article-title":"Efficacy and safety of ivermectin for treatment and prophylaxis of COVID-19 pandemic","volume":"3","author":"Elgazzar","year":"2020","journal-title":"Res Sq."},{"key":"B79","unstructured":"2020"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e23710","DOI":"10.1371\/journal.pone.0023710","article-title":"Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans","volume":"6","author":"Lang","year":"2011","journal-title":"PLoS ONE."},{"key":"B81","doi-asserted-by":"publisher","first-page":"08","DOI":"10.5530\/ijrhs.8.1.3","article-title":"Liposomal lactoferrin as potential preventative and cure for COVID-19","volume":"8","author":"Serrano","year":"2020","journal-title":"Int J Res Heal Sci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jiac.2014.08.003","article-title":"Lactoferrin for prevention of common viral infections","volume":"20","author":"Wakabayashi","year":"2014","journal-title":"J Infect Chemother."},{"key":"B83","doi-asserted-by":"publisher","first-page":"6997","DOI":"10.1007\/s00253-015-6818-4","article-title":"Antiviral activities of whey proteins","volume":"99","author":"Ng","year":"2015","journal-title":"Appl Microbiol Biotechnol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.antiviral.2007.03.012","article-title":"The anti-papillomavirus activity of human and bovine lactoferricin","volume":"75","author":"Mistry","year":"2007","journal-title":"Antiviral Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1386-6346(02)00088-8","article-title":"Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes","volume":"24","author":"Hara","year":"2002","journal-title":"Hepatol Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.virol.2014.01.022","article-title":"Inhibition of Mayaro virus infection by bovine lactoferrin","author":"Carvalho","year":"2014","journal-title":"Virology."},{"key":"B87","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.virol.2008.06.017","article-title":"Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein","volume":"379","author":"Chien","year":"2008","journal-title":"Virology."},{"key":"B88","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.antiviral.2006.09.002","article-title":"Bovine lactoferrin inhibits echovirus endocytic pathway by interacting with viral structural polypeptides","volume":"73","author":"Ammendolia","year":"2007","journal-title":"Antiviral Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12917-019-2067-6","article-title":"Antiviral effects of nisin, lysozyme, lactoferrin and their mixtures against bovine viral diarrhoea virus","volume":"15","author":"Ma\u0142aczewska","year":"2019","journal-title":"BMC Vet Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/BF01322673","article-title":"Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea","volume":"140","author":"Fujihara","year":"1995","journal-title":"Arch Virol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1159\/000336178","article-title":"Inhibition of epstein-barr virus infection by lactoferrin","volume":"4","author":"Zheng","year":"2012","journal-title":"J Innate Immun."},{"key":"B92","doi-asserted-by":"publisher","first-page":"10162","DOI":"10.1074\/jbc.M207879200","article-title":"Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein","volume":"278","author":"Nozaki","year":"2003","journal-title":"J Biol Chem."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1111\/j.1440-1746.2007.04858.x","article-title":"Effect of lactoferrin in patients with chronic hepatitis C: combination therapy with interferon and ribavirin","volume":"22","author":"Kaito","year":"2007","journal-title":"J Gastroenterol Hepatol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"7206","DOI":"10.1111\/j.1742-4658.2009.07400.x","article-title":"Viral entry mechanisms: Human papillomavirus and a long journey from extracellular matrix to the nucleus","volume":"276","author":"Sapp","year":"2009","journal-title":"FEBS J."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1651-2227.2007.00393.x","article-title":"Does daily intake of bovine lactoferrin-containing products ameliorate rotaviral gastroenteritis?","volume":"96","author":"Egashira","year":"2007","journal-title":"Acta Paediatr Int J Paediatr."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S1357-2725(98)00066-1","article-title":"Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection","volume":"30","author":"Puddu","year":"1998","journal-title":"Int J Biochem Cell Biol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1248\/jhs.56.613","article-title":"Inhibitory effect of bovine lactoferrin on human parainfluenza virus type 2 infection","volume":"56","author":"Yamamoto","year":"2010","journal-title":"J Heal Sci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"301.e1","DOI":"10.1016\/j.ijantimicag.2008.07.020","article-title":"Lactoferrin: structure, function and applications","volume":"33","author":"Gonz\u00e1lez-Ch\u00e1vez","year":"2009","journal-title":"Int J Antimicrob Agents."},{"key":"B99","doi-asserted-by":"publisher","first-page":"106118","DOI":"10.1016\/j.ijantimicag.2020.106118","article-title":"Lactoferrin as potential preventative and adjunct treatment for COVID-19","volume":"56","author":"Chang","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"B100","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/22221751.2021.1888660","article-title":"The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor","volume":"10","author":"Hu","year":"2021","journal-title":"Emerg Microbes Infect."},{"key":"B101","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/nu13020328","article-title":"Protective effects of lactoferrin against SARS-CoV-2 infection in vitro","volume":"13","author":"Salaris","year":"2021","journal-title":"Nutrients."},{"key":"B102","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.job.2022.01.007","article-title":"Impact of SARS-CoV-2 on saliva: TNF-?, IL-6, IL-10, lactoferrin, lysozyme, IgG, IgA, and IgM.","volume":"64","author":"Santos JG de","year":"2022","journal-title":"J Oral Biosci."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.992733\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T06:31:36Z","timestamp":1667802696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.992733\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":102,"alternative-id":["10.3389\/fnut.2022.992733"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2022.992733","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,7]]},"article-number":"992733"}}